Detection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-19.
JSON
De Marinis Y, Pesola AK, Söderlund Strand A, Norman A, Pernow G, Aldén M, Yang R, Rasmussen M
Infect Ecol Epidemiol 11 (1) 1993535 [2021-10-29; online 2021-10-29]
The COVID-19 pandemic presents great challenges on transmission prevention, and rapid diagnosis is essential to reduce the disease spread. Various diagnostic methods are available to identify an ongoing infection by nasopharyngeal (NPH) swab sampling. However, the procedure requires handling by health care professionals, and therefore limits the application in household and community settings. In this study, we aimed to determine if the detection of SARS-CoV-2 can be performed alternatively on saliva specimens by rapid antigen test. Saliva and NPH specimens were collected from 44 patients with confirmed COVID-19. To assess the diagnostic accuracy of point-of-care SARS-CoV-2 rapid antigen test on saliva specimens, we compared the performance of four test products. RT-qPCR was performed and NPH and saliva sampling had similar Ct values, which associated with disease duration. All four antigen tests showed similar trend in detecting SARS-CoV-2 in saliva, but with variation in the ability to detect positive cases. The rapid antigen test with the best performance could detect up to 67% of the positive cases with Ct values lower than 25, and disease duration shorter than 10 days. Our study therefore supports saliva testing as an alternative diagnostic procedure to NPH testing, and that rapid antigen test on saliva provides a potential complement to PCR test to meet increasing screening demand.
PubMed 34745449
DOI 10.1080/20008686.2021.1993535
Crossref 10.1080/20008686.2021.1993535
pii: 1993535
pmc: PMC8567870